Pyxis Oncology, Inc. (PYXS) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading PYXS…

Pyxis Oncology, Inc. (PYXS) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Pyxis Oncology, Inc.

PYXS · CIK 1782223

4 · Aug 14, 2026 · Director, Interim CEO Civik Thomas was granted 250.96K Stock Option (Right to Buy)

4

Director, Interim CEO Civik Thomas was granted 250.96K Stock Option (Right to Buy)

Filed: Aug 14, 2026
Period: Aug 12, 2026
Accession: 0001193125-26-352206
Filer: Pyxis Oncology, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov